Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

References

• Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292(7)344–347
   PubMed Web of Science ®Google Scholar
• Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70(6)360–374
   PubMed Web of Science ®Google Scholar
• Mimori T. Autoantibodies in connective tissue diseases: Clinical significance and analysis of target autoantigens. Intern Med 1999; 38(7)523–532
   PubMedGoogle Scholar
• Arnett FC, Hirsch TJ, Bias WB, Nishikai M, Reichlin M. The Jo-1 antibody system in myositis: Relationships to clinical features and HLA. J Rheumatol 1981; 8(6)925–930
   PubMedGoogle Scholar
• Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 1996; 14(3)263–274
   PubMed Web of Science ®Google Scholar
• Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002; 47(6)614–622
   PubMedGoogle Scholar
• Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983; 26(5)604–611
   PubMedGoogle Scholar
• Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB, Turner-Warwick M, Hughes GR. Anti-Jo-1 antibody: A marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) 1984; 289(6438)151–152
   PubMed Web of Science ®Google Scholar
• Calabrese LH, Mitsumoto H, Chou SM. Inclusion body myositis presenting as treatment-resistant polymyositis. Arthritis Rheum 1987; 30(4)397–403
   PubMedGoogle Scholar
• Lerner MR, Steitz JA. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1979; 76(11)5495–5499
   PubMed Web of Science ®Google Scholar
• Forman MS, Nakamura M, Mimori T, Gelpi C, Hardin JA. Detection of antibodies to small nuclear ribonucleoproteins and small cytoplasmic ribonucleoproteins using unlabeled cell extracts. Arthritis Rheum 1985; 28(12)1356–1361
   PubMedGoogle Scholar
• Mimori T, Hardin JA, Steitz JA. Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem 1986; 261(5)2274–2278
   PubMedGoogle Scholar
• Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: A review. J Invest Dermatol 1993; 100(1)124S–127S
   Google Scholar
• Gelpi C, Kanterewicz E, Gratacos J, Targoff IN, Rodriguez-Sanchez JL. Coexistence of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum 1996; 39(4)692–697
   PubMedGoogle Scholar
• Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992; 35(4)449–456
   PubMed Web of Science ®Google Scholar
• Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990; 33(9)1361–1370
   PubMedGoogle Scholar
• Schnabel A, Reuter M, Biederer J, Richter C, Gross WL. Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment. Semin Arthritis Rheum 2003; 32(5)273–284
   PubMed Web of Science ®Google Scholar
• Harigai M, Hara M, Kamatani N, Kashiwazaki S. Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases. Ryumachi 1999; 39(6)819–828
   PubMedGoogle Scholar
• Targoff IN, Arnett FC. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990; 88(3)241–251
   PubMedGoogle Scholar
• Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol 1990; 144(5)1737–1743
   PubMed Web of Science ®Google Scholar
• Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, Akizuki M, Targoff IN. Anti-KS: Identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999; 162(4)2315–2320
   PubMed Web of Science ®Google Scholar
• Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985; 28(7)796–803
   PubMedGoogle Scholar
• Reichlin M, Maddison PJ, Targoff I, Bunch T, Arnett F, Sharp G, Treadwell E, Tan EM. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol 1984; 4(1)40–44
   PubMedGoogle Scholar
• Mierau R, Dick T, Bartz-Bazzanella P, Keller E, Albert ED, Genth E. Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum 1996; 39(5)868–876
   PubMedGoogle Scholar
• Douglas WW, Tazelaar HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, Ryu JH. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164(7)1182–1185
   PubMed Web of Science ®Google Scholar
• Takizawa H, Shiga J, Moroi Y, Miyachi S, Nishiwaki M, Miyamoto T. Interstitial lung disease in dermatomyositis: Clinicopathological study. J Rheumatol 1987; 14(1)102–107
   PubMed Web of Science ®Google Scholar
• Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996; 26(1)459–467
   PubMed Web of Science ®Google Scholar
• Fernandes L, Goodwill CJ. Dermatomyositis without apparent myositis, complicated by fibrosing alveolitis. J R Soc Med 1979; 72(10)777–779
   PubMedGoogle Scholar
• High WA, Cohen JB, Murphy BA, Costner MI. Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis. J Am Acad Dermatol 2003; 49(2)295–298
   PubMed Web of Science ®Google Scholar
• Sontheimer RD. Dermatomyositis: An overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 2002; 20(3)387–408
   PubMed Web of Science ®Google Scholar
• Olsen NJ, Park JH, King LE, Jr. Amyopathic dermatomyositis. Curr Rheumatol Rep 2001; 3(4)346–351
   PubMedGoogle Scholar